Florence Ranchon

1.3k total citations
58 papers, 812 citations indexed

About

Florence Ranchon is a scholar working on Geriatrics and Gerontology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Florence Ranchon has authored 58 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Geriatrics and Gerontology, 16 papers in Oncology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Florence Ranchon's work include Pharmaceutical Practices and Patient Outcomes (22 papers), Pharmaceutical studies and practices (12 papers) and Medication Adherence and Compliance (9 papers). Florence Ranchon is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (22 papers), Pharmaceutical studies and practices (12 papers) and Medication Adherence and Compliance (9 papers). Florence Ranchon collaborates with scholars based in France, United States and Switzerland. Florence Ranchon's co-authors include Catherine Rioufol, Vérane Schwiertz, Nicolas Vantard, Gilles Salles, Benoît You, Gilles Freyer, Stéphanie Parat, Émilie Hénin, V. Trillet-Lenoir and Claude Dussart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Florence Ranchon

51 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Ranchon France 16 236 195 146 132 96 58 812
Catherine Rioufol France 17 245 1.0× 246 1.3× 148 1.0× 145 1.1× 99 1.0× 89 969
Vérane Schwiertz France 14 170 0.7× 151 0.8× 129 0.9× 103 0.8× 52 0.5× 31 607
Ana Herranz‐Alonso Spain 16 230 1.0× 117 0.6× 140 1.0× 128 1.0× 100 1.0× 80 876
Nicolas Vantard France 14 201 0.9× 134 0.7× 140 1.0× 104 0.8× 41 0.4× 29 591
Émilie Hénin France 17 111 0.5× 191 1.0× 83 0.6× 184 1.4× 48 0.5× 49 778
Raymond J. Muller United States 10 231 1.0× 163 0.8× 104 0.7× 233 1.8× 203 2.1× 20 822
Kate Traynor United States 13 198 0.8× 114 0.6× 99 0.7× 74 0.6× 44 0.5× 422 1.1k
John Valgus United States 14 252 1.1× 88 0.5× 52 0.4× 174 1.3× 141 1.5× 36 643
B. Gourieux France 12 217 0.9× 113 0.6× 90 0.6× 78 0.6× 49 0.5× 58 503
Vicente Escudero‐Vilaplana Spain 15 128 0.5× 159 0.8× 44 0.3× 120 0.9× 75 0.8× 78 762

Countries citing papers authored by Florence Ranchon

Since Specialization
Citations

This map shows the geographic impact of Florence Ranchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Ranchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Ranchon more than expected).

Fields of papers citing papers by Florence Ranchon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Ranchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Ranchon. The network helps show where Florence Ranchon may publish in the future.

Co-authorship network of co-authors of Florence Ranchon

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Ranchon. A scholar is included among the top collaborators of Florence Ranchon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Ranchon. Florence Ranchon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kefleyesus, Amaniel, Naoual Bakrin, Florence Ranchon, et al.. (2024). Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis. European Journal of Surgical Oncology. 50(2). 107955–107955. 6 indexed citations
3.
Rioufol, Catherine, et al.. (2023). Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients. Annales Pharmaceutiques Françaises. 81(5). 900–908. 1 indexed citations
4.
Baudouin, Anne, et al.. (2023). Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine. Journal of Cancer Research and Clinical Oncology. 149(14). 13301–13310. 2 indexed citations
5.
Huot, Laure, et al.. (2023). Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer. Journal of the American Geriatrics Society. 72(2). 567–578. 3 indexed citations
6.
Ranchon, Florence, Étienne Chatelut, Juliette Lambert, et al.. (2023). Anticorps monoclonaux conjugués et bispécifiques en cancérologie – compte rendu de la Journée de Saint Louis 2022. Bulletin du Cancer. 110(12). 1343–1351. 4 indexed citations
7.
Rioufol, Catherine, Nicolas Vantard, Alexandre Teixeira, et al.. (2022). Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer. Journal of Oncology Pharmacy Practice. 29(3). 750–754.
8.
Baudouin, Anne, et al.. (2021). Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases. Journal of Cancer Research and Clinical Oncology. 148(3). 707–718. 30 indexed citations
9.
Ranchon, Florence, et al.. (2020). Do systemic treatments delivered after Nivolumab result in better outcomes? A bicentric case-control study. Respiratory Medicine and Research. 77. 100–105. 1 indexed citations
10.
Parat, Stéphanie, et al.. (2020). Economic impact of clinical pharmaceutical activities in hospital wards: A systematic review. Research in Social and Administrative Pharmacy. 17(3). 497–505. 9 indexed citations
11.
Saux, Olivia Le, Aurélie Bourmaud, Catherine Rioufol, et al.. (2018). Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients. Cancer Chemotherapy and Pharmacology. 82(2). 319–327. 15 indexed citations
12.
Fargier, Emilie, Nicolas Vantard, Florence Ranchon, et al.. (2017). Évolution du remboursement des anticancéreux inscrits sur la liste en sus : impact financier au sein d’un centre hospitalo-universitaire. Bulletin du Cancer. 104(6). 538–551. 2 indexed citations
13.
Damaj, Gandhi, Jérôme Cornillon, Krimo Bouabdallah, et al.. (2017). Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplantation. 52(7). 941–949. 13 indexed citations
14.
Bourmaud, Aurélie, Émilie Hénin, Fabien Tinquaut, et al.. (2015). Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods. BMC Research Notes. 8(1). 291–291. 21 indexed citations
15.
Ranchon, Florence, Thierry Vial, Catherine Rioufol, et al.. (2015). Concomitant drugs with low risks of drug–drug interactions for use in oncology clinical trials. Critical Reviews in Oncology/Hematology. 94(2). 189–200. 8 indexed citations
16.
Ranchon, Florence, Lila Gilis, Vérane Schwiertz, et al.. (2015). Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(4). 723–730. 58 indexed citations
17.
Ranchon, Florence, Audrey Nosbaum, Benoît You, et al.. (2014). Hypersensitivity to oxaliplatin: clinical features and risk factors. BMC Pharmacology and Toxicology. 15(1). 1–1. 70 indexed citations
18.
Ranchon, Florence, Benoît You, Gilles Salles, et al.. (2012). Predictors of prescription errors involving anticancer chemotherapy agents. European Journal of Cancer. 48(8). 1192–1199. 32 indexed citations
19.
Ranchon, Florence, Gilles Salles, Hans-Martin Späth, et al.. (2011). Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer. 11(1). 478–478. 93 indexed citations
20.
Ranchon, Florence, Maurice Laville, Denis Fouque, et al.. (2010). Coût médical direct des agents stimulant l’érythropoïèse dans le traitement de l’anémie chez le patient insuffisant rénal chronique : revue de la littérature. Néphrologie & Thérapeutique. 6(2). 97–104. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026